Douglas V, Rachapudi S, Davila-Siliezar P, Laylani N, Lee A
Ophthalmol Ther. 2024; 13(6):1417-1425.
PMID: 38587773
PMC: 11109035.
DOI: 10.1007/s40123-024-00932-z.
Bonnan M, Debeugny S
Front Neurol. 2023; 14:1305093.
PMID: 38130834
PMC: 10733536.
DOI: 10.3389/fneur.2023.1305093.
Heron E, Sedira N, Dahia O, Jamart C
J Clin Med. 2022; 11(7).
PMID: 35407604
PMC: 8999894.
DOI: 10.3390/jcm11071997.
Ellis C, Hamer D, Hunt R, Lever A, Lever R, Peart W
Br Med J. 2010; 2(5417):1093-8.
PMID: 20790334
PMC: 1817062.
DOI: 10.1136/bmj.2.5417.1093.
Moschos M, Guex-Crosier Y
Clin Ophthalmol. 2009; 3:111-5.
PMID: 19668553
PMC: 2709022.
Risk factors for early visual deterioration in temporal arteritis.
Loddenkemper T, Sharma P, Katzan I, Plant G
J Neurol Neurosurg Psychiatry. 2007; 78(11):1255-9.
PMID: 17504884
PMC: 2117585.
DOI: 10.1136/jnnp.2006.113787.
Steroid management in giant cell arteritis.
Chan C, Paine M, ODay J
Br J Ophthalmol. 2001; 85(9):1061-4.
PMID: 11520757
PMC: 1724128.
DOI: 10.1136/bjo.85.9.1061.
The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis after the first two months of treatment.
Kyle V, Hazleman B
Ann Rheum Dis. 1993; 52(12):847-50.
PMID: 8311533
PMC: 1005213.
DOI: 10.1136/ard.52.12.847.
Tonic pupil with giant cell arteritis.
Currie J, Lessell S
Br J Ophthalmol. 1984; 68(2):135-8.
PMID: 6691957
PMC: 1040271.
DOI: 10.1136/bjo.68.2.135.
Occult temporal arteritis. A common cause of blindness in old age.
Cullen J
Br J Ophthalmol. 1967; 51(8):513-25.
PMID: 6035952
PMC: 506438.
DOI: 10.1136/bjo.51.8.513.
Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up.
Kyle V, Cawston T, Hazleman B
Ann Rheum Dis. 1989; 48(8):667-71.
PMID: 2782977
PMC: 1003844.
DOI: 10.1136/ard.48.8.667.
Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.
Kyle V, Hazleman B
Ann Rheum Dis. 1989; 48(8):658-61.
PMID: 2782975
PMC: 1003842.
DOI: 10.1136/ard.48.8.658.
Plasma viscosity or erythrocyte sedimentation rate in the diagnosis of giant cell arteritis?.
Brittain G, McIlwaine G, Bell J, Gibson J
Br J Ophthalmol. 1991; 75(11):656-9.
PMID: 1751458
PMC: 1042520.
DOI: 10.1136/bjo.75.11.656.
Cortical blindness in cranial arteritis.
Chisholm I
Br J Ophthalmol. 1975; 59(6):332-3.
PMID: 1174488
PMC: 1042630.
DOI: 10.1136/bjo.59.6.332.
Controversies regarding giant cell (temporal, cranial) arteritis.
Eshaghian J
Doc Ophthalmol. 1979; 47(1):43-67.
PMID: 391520
DOI: 10.1007/BF00145369.